Shinta Cheng
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Treatment and Research 25
- Prostate Cancer Diagnosis and Treatment 4
- Oncology 12
- PARP inhibition in cancer therapy 6
- Cancer Treatment and Pharmacology 5
- Co-authors
- Simon Chowdhury (10 shared papers)Kim N. (7 shared papers)Margaret K. Yu (6 shared papers)Dingwei Ye (2 shared papers)Byung Ha Chung (2 shared papers)Kris Deprince (2 shared papers)Robert Given (2 shared papers)Mustafa Özgüroğlu (2 shared papers)
- Journals
- Journal of Clinical Oncology (21 papers)Clinical Cancer Research (3 papers)The Journal of Urology (3 papers)Annals of Oncology (3 papers)Blood (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Shinta Cheng
38 papers receiving 1.6k citations
Shinta Cheng's Hit Papers
Peers
Comparison fields: 5 of 55
- Pulmonary and Respiratory Medicine 1.2k
- Cancer Research 284
- Radiology, Nuclear Medicine and Imaging 312
- Oncology 334
- Hematology 139
Countries citing papers authored by Shinta Cheng
This map shows the geographic impact of Shinta Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinta Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinta Cheng more than expected).
Fields of papers citing papers by Shinta Cheng
This network shows the impact of papers produced by Shinta Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinta Cheng. The network helps show where Shinta Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Shinta Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer Hit paper breakdown → | 2019 | 927 |
| 2 | 2019 | 188 | |
| 3 | 2009 | 178 | |
| 4 | 2019 | 73 | |
| 5 | 2013 | 36 | |
| 6 | 2005 | 26 | |
| 7 | 2008 | 26 | |
| 8 | 2005 | 23 | |
| 9 | 2005 | 23 | |
| 10 | 2022 | 19 | |
| 11 | 2020 | 17 | |
| 12 | 2006 | 15 | |
| 13 | 2019 | 13 | |
| 14 | 2019 | 12 | |
| 15 | 2019 | 8 | |
| 16 | 2020 | 6 | |
| 17 | 2019 | 5 | |
| 18 | 2018 | 4 | |
| 19 | 2020 | 3 | |
| 20 | 2020 | 3 |
About Shinta Cheng
Shinta Cheng is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Hematology, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (25 papers), Radiopharmaceutical Chemistry and Applications (9 papers), Cancer, Lipids, and Metabolism (7 papers), PARP inhibition in cancer therapy (6 papers), Cancer Treatment and Pharmacology (5 papers), Multiple Myeloma Research and Treatments (5 papers), Cancer Genomics and Diagnostics (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Cancer Research (284 citations), Radiology, Nuclear Medicine and Imaging (312 citations), Oncology (334 citations) and Hematology (139 citations). Shinta Cheng has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Simon Chowdhury, Kim N., Margaret K. Yu, Dingwei Ye, Byung Ha Chung, Kris Deprince, Robert Given, Mustafa Özgüroğlu, Jinhui Li and Álvaro Juárez Soto. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, The Journal of Urology, Annals of Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.